ArticleCurrent medical mycology2016
Susceptibility pattern of
Article in Current medical mycology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Vulvovaginal candidiasis among Yemeni women: prevalence of Candida species, biofilm formation rates, antifungal susceptibility patterns, and biofilm-associated genes ALS1 and HWP1.BMC microbiology · 2026Article
- Species Distribution, Antifungal Resistance, and Risk Factors ofInfection and drug resistance · 2026Article
- Antifungal Resistance of ClinicalIranian journal of public health · 2023Review
- Antibiofilm Potential and Exoenzyme Inhibition byLife (Basel, Switzerland) · 2022Article
- Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon.BMC infectious diseases · 2020Article
- Identification ofCurrent medical mycology · 2017Article
- The efficacy of gaseous ozone against different forms ofCurrent medical mycology · 2017Article
- In vitro activity of kombucha tea ethyl acetate fraction againstCurrent medical mycology · 2016Article
- The Evaluation of the virulence factors of clinicalCurrent medical mycology · 2016Article
- Identification ofCurrent medical mycology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeCandidiasis is a major fungal infection, and MATERIALS AND
methodsClinical samples were cultured on Sabouraud dextrose agar and were incubated at room temperature for seven days. The isolates were transferred to Professor Alborzi Clinical Microbiology Research Center, Shiraz, Iran.
resultsOverall, 397
conclusionAccording to our data, fluconazole is the drug of choice for management of patients at risk for systemic candidiasis throughout the region, since it is cost-effective with low side effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.